Jeremy Grantham Thermo Fisher Scientific Inc. Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

$30.8 Billion
Q1 2025

A detailed history of Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Grantham, Mayo, Van Otterloo & Co. LLC holds 1,456,080 shares of TMO stock, worth $588 Million. This represents 2.35% of its overall portfolio holdings.

Number of Shares

1,456,080

Previous 1,093,866 33.11%

Holding current value

$588 Million

Previous $569 Million 27.32%

% of portfolio

2.35%

Previous 1.91%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$497.6 - $606.74 $180 Million - $220 Million	362,214 Added 33.11%	1,456,080 $725 Million
Q4 2024 Feb 13, 2025	BUY	$501.29 - $612.85 $321 Million - $392 Million	639,467 Added 140.73%	1,093,866 $569 Million
Q3 2024 Nov 13, 2024	BUY	$531.86 - $624.21 $15.3 Million - $18 Million	28,760 Added 6.76%	454,399 $281 Million
Q2 2024 Aug 13, 2024	BUY	$541.52 - $599.02 $230 Million - $255 Million	425,639 New	425,639 $235 Million
Q3 2022 Nov 10, 2022	BUY	$507.19 - $604.49 $1.37 Million - $1.63 Million	2,700 New	2,700 $1.37 Million
Q4 2018 Feb 13, 2019	SELL	$208.47 - $251.98 $687,951 - $831,534	-3,300 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$205.57 - $244.32 $61,671 - $73,296	-300 Reduced 8.33%	3,300 $805,000
Q1 2018 May 15, 2018	SELL	$192.98 - $224.11 $38,596 - $44,822	-200 Reduced 5.26%	3,600 $743,000
Q4 2017 Feb 14, 2018	BUY	$182.03 - $200.37 $382,263 - $420,777	2,100 Added 123.53%	3,800 $722,000
Q3 2017 Nov 14, 2017	BUY	$171.74 - $194.04 $291,958 - $329,868	1,700	1,700 $322,000

Others Institutions Holding TMO

# of Institutions

2,907

Shares Held

339M

Call Options Held

1.91M

Put Options Held

2.16M

View Full List

About THERMO FISHER SCIENTIFIC INC.

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $158B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

More about TMO

Track Jeremy Grantham's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.

Account